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Abstract
In healthcare supply management, the 
physician’s role in supply selection, 
driven largely by their clinical exper-
tise, directly impacts hospital cost 
performance. Previous research sug-
gests physicians have limited regard to 
the cost implications of supplies they 
use or prescribe, even when it does 
not adversely impact clinical quality. 
The purpose of this study is to assess 
the perceived importance and atten-
tion that physicians give to the costs of 
medical supplies in a public healthcare 
system and compares between physi-
cian cost perceptions of pharmaceutical 
products and medical devices. Physi-
cians working in Kuwait’s public health 
sector were asked to estimate the cost 
of 18 common pharmaceutical products 
and medical devices. Estimates within 
25 percent of the actual cost were con-
sidered accurate. One-hundred and 
four responses were gathered from 
physicians working in Kuwait’s public 
health sector. On average, physicians 
accurately estimated only 22 percent 
of pharmaceutical products and 14 
percent of medical devices. Physicians 
indicated cost should be an important 
supply selection criterion but generally 
indicated limited accessibility to cost 
information. Hospital administrators 
should consider increasing accessibility 
to cost information and involving physi-
cian leaders in procurement and supply 
rationalization initiatives. Education 
about supply management and cost 
containment may hold value for both 
physicians and the healthcare system.
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Introduction
Healthcare delivery requires many components in order to be effective and efficient. An 
important and often overlooked component is the supply chain of medical supplies and 
equipment. Supply chain management is the discipline that manages the procurement, 
production, and logistics functions involved in moving goods and services to custom-
ers. Health sector supply chains form particularly complex networks with many players 
involved. A combination of several characteristics found in these supply chains distin-
guishes them from others: a high degree of intermediation, high level of regulation, the 
range and criticality of healthcare supplies, and the mission of healthcare organisations 
Hospital supply expenses account for the second largest cost category at hospitals after 
salary expenses, with pharmaceuticals and medical devices accounting for most of the 
spend. Even after excluding non-medical supplies (food, equipment, linens, mainte-
nance supplies, and so forth), pharmaceuticals and medical devices generally make up 15 
percent of total hospital expenditure.1 Many studies have identified ample opportunities 
to improve healthcare’s supply chain performance, but the complex nature of this supply 
chain presents many challenges that hinder this pursuit.2
Supply expenses vary drastically across different patients and different treatment needs. 
Surprisingly, similar patients receiving the same treatment plan may each incur signifi-
cantly different supply costs depending on the institution where patients are being treated 
and the physician that treats them. Many times, different treatment paths emanate from 
the nature of physicians’ professional work, characterised by autonomy and knowledge 
intensity. Price differences for the same product at different hospitals may be a result of 
different contracts and negotiation with the manufacturers, who generally guard pricing 
information so hospitals and physicians cannot easily compare product costs.3 A recent 
study shows that medical device costs may be multiple times more expensive across 
countries.4 Significant price variations in supplies have also been observed across hospi-
tals within the same city.5 This is particularly true in supply-intensive specialties such as 
1   Yousef Abdulsalam and Eugene Schneller, ‘Hospital Supply Expenses: An Important Ingredient in Health 
Services Research’, Medical Care Research and Review, 24 July 2017, https://doi.org/10.1177/1077558717719928.
2   Vikram Bhakoo and Thomas Y. Choi, ‘The Iron Cage Exposed: Institutional Pressures and Heterogeneity 
across the Healthcare Supply Chain’, Journal of Operations Management 31, no. 6 (September 2013): pp. 
432–49, https://doi.org/10.1016/j.jom.2013.07.016; Kathleen E. McKone-Sweet, Paul Hamilton, and Susan 
B. Willis, ‘The Ailing Healthcare Supply Chain: A Prescription for Change’, The Journal of Supply Chain 
Management 41, no. 1 (December 2005): pp. 4–17, https://doi.org/10.1111/j.1745-493X.2005.tb00180.x.
3   Mark V. Pauly and Lawton R. Burns, ‘Price Transparency For Medical Devices’, Health Affairs 27, no. 6 
(1 November 2008): pp. 1544–53, https://doi.org/10.1377/hlthaff.27.6.1544.
4   Martin Wenzl and Elias Mossialos, ‘Prices For Cardiac Implant Devices May Be Up To Six Times 
Higher In The US Than In Some European Countries’, Health Affairs 37, no. 10 (1 October 2018): pp. 
1570–77, https://doi.org/10.1377/hlthaff.2017.1367.
5   Reed Abelson, ‘Pricing Power at Risk for Orthopedics Makers’, The New York Times, 29 June 2006, 
sec. Business, http://www.nytimes.com/2006/06/29/business/29place.html; James C. Robinson et al., 
‘Variability in Costs Associated with Total Hip and Knee Replacement Implants’, The Journal of Bone 
and Joint Surgery. American Volume 94, no. 18 (19 September 2012): pp. 1693–98, https://doi.org/10.2106/
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cardiology and orthopedics, where the cost of supplies forms a significant portion of the 
total cost of patient treatment.6 Even with relatively low-cost pharmaceuticals, differences 
between branded drugs and generic drugs over a patient’s treatment cycle may translate 
to thousands of dollars.7 
A major player in the healthcare supply chain is the physician, who selects the supplies 
on behalf of the patient and sometimes directly administers them. Estimates suggest that 
physicians have direct influence over 60 percent of hospital supply expenditure.8 And 
while they hold a significant amount of knowledge about the properties and applications 
of medical supplies, physicians generally pay little attention to their costs and sourcing 
implications.9 It is unclear how aware physicians are about the costs of devices and phar-
maceuticals they commonly select for use.
To gauge physician cost awareness, this study developed and administered a survey asking 
physicians practicing in Kuwait’s public health sector to estimate the costs of highly rec-
ognised medical products. While physicians showed strong familiarity with the medical 
items presented, they conveyed limited cost knowledge.
Kuwait’s health system provides a case study that can be generalised to public health 
systems that span a small-to-medium size metropolitan region. For example, Kuwait’s 
system can be conceptualised as a self-contained Accountable Care Organization (ACO), 
a model (whereby a group of healthcare providers collaborate in the care and treatment of 
a pre-defined population or region) that is becoming increasingly common in the United 
States.10 The availability of funding, access to human resources, and abundance of hospital 
bed capacity in the country allow such a health system to focus on developing the compo-
nents of healthcare delivery, such as the health sector supply chain, rather than scurrying 
to meet basic healthcare demand.
JBJS.K.00355.
6   Kanu Okike et al., ‘Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They 
Implant’, Health Affairs 33, no. 1 (1 January 2014): pp. 103–9, https://doi.org/10.1377/hlthaff.2013.0453.
7   William H. Shrank et al., ‘The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More 
Cost-Effective Than Thought, And May Save Money’, Health Affairs 30, no. 7 (1 July 2011): pp. 1351–57, 
https://doi.org/10.1377/hlthaff.2010.0431.
8   J. C. Lerner et al., ‘The Consequence Of Secret Prices: The Politics Of Physician Preference Items’, 
Health Affairs 27, no. 6 (1 November 2008): pp. 1560–65, https://doi.org/10.1377/hlthaff.27.6.1560.
9   G. Michael Allan, Joel Lexchin, and Natasha Wiebe, ‘Physician Awareness of Drug Cost: A Systematic 
Review’, ed. Suzanne Hill, PLoS Medicine 4, no. 9 (25 September 2007): e283, https://doi.org/10.1371/
journal.pmed.0040283.
10   Lawton R. Burns and Mark V. Pauly, ‘Accountable Care Organizations May Have Difficulty Avoiding 
The Failures Of Integrated Delivery Networks Of The 1990s’, Health Affairs 31, no. 11 (November 2012): 
pp. 2407–16.
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Background
Kuwait’s demand for healthcare services has been increasing rapidly, driven by an increase 
in population, greater life expectancy, and lower infant mortality. Despite a highly affluent 
population that enjoys a high per-capita GDP, the population suffers from high rates of 
non-communicable diseases, such as diabetes, cardiovascular diseases, and cerebrovas-
cular diseases.11 These factors, among others, have placed a significant burden on Kuwait’s 
healthcare system. Although Kuwait’s health spending relative to GDP (4 percent) may 
not appear high compared to the world average (9.9 percent), government health expen-
diture exceeded $5 billion USD or $1,200 per capita in 2015.12 Compared to its GCC peers, 
Kuwait’s healthcare supplies expenditure is higher as a percentage of total expenditure 
and as a percentage of GDP.13
In Kuwait, public health expenditure on pharmaceuticals and medical devices in 2015 was 
estimated at 800 million USD (243 million KWD), up from 580 million USD (177 million 
KWD) in 2012.12 Kuwait’s hospital supply expenditure makes up approximately 16 percent 
of total hospital expenses. The Central Medical Stores, a department in Kuwait’s Ministry 
of Health, is responsible for the procurement of medical supplies for public health institu-
tions, aggregating their procurement requests and negotiating contracts with international 
suppliers for pharmaceuticals, consumables, capital goods, and medical devices.
Approximately 65% of the Kuwaiti population is covered by a public health plan, with 
expatriates paying subsidised fees for non-emergency health services.14 The public health 
sector accounts for 80% of patient discharges in the country, with six general hospitals and 
eleven specialty care hospitals.15 An unintended consequence is a limited attention given 
to the costs of the pharmaceuticals and medical devices. Physicians have little incentive to 
factor costs in their decision-making even when considering clinically equivalent alterna-
tives as it impacts neither their clinical work nor their compensation. An indication of this 
is the very low market penetration of generic drugs in the country, where generic prod-
ucts account for only 21.6% of the total volume of prescribed drugs. In contrast, generic 
drugs accounted for 89% of prescriptions in the United States16 and 81% in the United 
Kingdom.17 The limited incentives to reduce costs may be driven by the universal health 
11   Kuwait Ministry of Health, ‘World Health Survey in Kuwait: Summary Report 2013’ (Kuwait, 2015).
12   Kuwait Ministry of Health, ‘Annual Health Report 2015: 52nd Edition’ (National Centre for Health 
Information Health & Vital Statistics Division, 2017); The World Bank, ‘World Health Organization 
Global Health Expenditure Database’, 2015.
13   BMI, ‘Kuwait Pharmaceutical & Healthcare Report’, 2017.
14   IMS Health, ‘Market Overview 2016, Kuwait’, 2016, https://www.tfhc.nl/wp-content/uploads/2017/08/
KLSC-IMS-Kuwait-Health-Industry-Report-2016-vF2.pdf
15   IMS Health.
16   Association for Accessible Medicines, ‘2017 Generic Drug Access and Savings in the U.S. Report’, 2017, 
https://accessiblemeds.org/resources/blog/2017-generic-drug-access-and-savings-us-report
17   NHS Business Services Authority, ‘Medicines Optimisation - Generic Prescribing’ (National Health 
Services, 2018), https://www.nhsbsa.nhs.uk/epact2/dashboards-specifications/medicines-optimisation-
generic-prescribing
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coverage in the country, which gives physicians even less reason to be concerned about 
costs. However, limited cost awareness among physicians is not only observed in coun-
tries with universal healthcare.18 The medical devices industry poses a greater challenge 
with even less price transparency and product alternatives relative to the pharmaceuticals 
industry, even in mature health systems. 
Despite the physician’s important role in supply selection and hospital costs, they receive 
limited education in healthcare supply management.19 The medical college in Kuwait is 
no exception as medical students receive no training or education about hospital opera-
tions and supply chain management. Substitutable supply options (i.e., different brands 
of the same medical item) vary greatly in terms of their costs. Between two clinically 
equivalent medical items, physicians generally select one based on their personal experi-
ence, training, and relationship with supplier representatives rather than on the basis of 
cost.20 Supplier representatives frequently interact with physicians to present them with 
new technologies, educate them about products, and provide clinical assistance related 
to the technical products. Strong relationships form between physicians and supplier rep-
resentatives, which naturally18 influences physician decision-making via the ‘value-added’ 
services that some brands provide directly to the practitioners.21
Previous studies have demonstrated the lack of awareness that physicians hold with 
regards to drug costs. Our study extends this line of inquiry further by assessing physician 
cost perceptions of both pharmaceuticals and medical devices and attempts to determine 
the factors that provide physicians with more knowledge about supply costs. Specifically, 
we consider physicians in Kuwait, a country that provides universal health coverage to an 
affluent population, but whose medical supply spending exceeds its neighboring peers.22
Methods
Survey Instrument
A survey instrument was developed to measure physicians’ cost perceptions. In total, the 
survey was confined to 30 questions to ensure that the time required to complete did not 
exceed ten minutes. The survey was presented in an electronic format and made acces-
sible online. The first section of the survey asked physicians to estimate the cost of 18 
medical items. The second section of the survey asked respondents to answer 12 general 
and demographic questions.
18   Allan, Lexchin, and Wiebe, ‘Physician Awareness of Drug Cost.’
19   Jim Eckler and Eugene S. Schneller, ‘Physician Leaders’ Roles in Supply Chain Management’, Physician 
Leadership Journal 2, no. 6 (November 2015): pp. 22–25.
20   Okike et al., ‘Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They Implant.’
21   Lawton R. Burns et al., ‘Implant Vendors and Hospitals: Competing Influences over Product Choice 
by Orthopedic Surgeons’, Health Care Management Review 34, no. 1 (January 2009): pp. 2–18, https://doi.
org/10.1097/01.HMR.0000342984.22426.ac
22   BMI, ‘Kuwait Pharmaceutical & Healthcare Report.’
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The first section of the survey presented physicians with eight different pharmaceutical 
drugs and ten different medical devices. The drugs in the survey were selected to ensure 
that the majority of physicians, regardless of their specialty, would recognise them. Several 
steps were taken to ensure this outcome. First, we reviewed the literature to aggregate 
a list of drugs used in similar studies.23 Subsequently, a focus group, composed of four 
physicians from various specialties, was consulted to refine this list and identify drugs 
that are commonly used in Kuwait’s hospital environment. Finally, the refined list was 
cross-referenced with the World Health Organization’s List of Essential Medicines.24 The 
final list consisted of eight drugs commonly prescribed to hospital patients. A picture of 
each drug’s packaging was displayed in the survey.
Ten medical supplies were selected after discussion with the focus group, ensuring high 
recognisability of items and a wide price range. Items ranged from a few dollars to several 
thousand dollars. To avoid haphazard guessing, respondents could skip items they did 
not recognise. A picture of each medical item was displayed in the survey. Physicians were 
then asked to respond to questions about (1) their overall knowledge of the listed items, 
(2) their confidence in the estimates they provided, (3) the accessibility of cost informa-
tion at their institution, and (4) their perceived importance of costs. Finally, demographic 
information about the physicians was collected.
The survey instrument is presented in Appendix A.
Data Collection
The target respondents were physicians working in Kuwait’s public health sector. Our 
inquiry was not confined to a specific clinical specialty or physician rank. A convenience 
sampling approach was taken to maximise potential respondents, using the ‘snowball 
sampling’ approach. The researchers disseminated survey links with a concise explanation 
of the study to their physician contacts (mainly via WhatsApp), who were then asked to 
relay the message to their colleagues in turn and report the number of people the message 
was forwarded to. The data collection period occurred in October 2018 for a period of 
three weeks with reminder messages sent ten days after the initial request. Approximately 
50 percent of the responses were received within the first four days of data collection.
For the medical items included in the survey, data about the actual cost (on the health 
system) was obtained from several sources. Wholesale and retail drug prices are regu-
lated by the Ministry of Health’s Pharmaceuticals and Herbal Medicines Registration & 
Control Administration and published on their website.25 For medical devices, the prices 
23   G. Michael Allan and Grant D Innes, ‘Do Family Physicians Know the Costs of Medical Care? Survey 
in British Columbia’, Canadian Family Physician February 50, no. 2 (February 2004): pp. 263–70; Allan, 
Lexchin, and Wiebe, ‘Physician Awareness of Drug Cost’; Lisa Korn et al., ‘Improving Physicians’ 
Knowledge of the Costs of Common Medications and Willingness to Consider Costs When Prescribing 
| SpringerLink’, Journal of General Internal Medicine 18, no. 1 (January 2003): pp. 31–7.
24   World Health Organization, ‘The Selection and Use of Essential Medicines 2017’, March 2017.
25   State of Kuwait Ministry of Health, ‘Drug & Food Supplement Prices’, 2018, https://eservices.moh.gov.
kw/drugdetails.aspx
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that apply to public hospitals were obtained from the largest medical supplies distributor 
in Kuwait. The provided pricing data was cross-checked with a hospital’s procurement 
representative and found to be reliable.
Analysis
We compared the estimates that physicians provided with their actual costs to determine 
the rate of accuracy in estimating medical items. This is done by first calculating the abso-
lute value of the difference between the estimate and actual cost and then dividing that 
by the actual cost for each physician-item observation. A binary variable is then assigned 
to indicate whether the estimate is accurate within a 25% margin of error. In other words, 
if a provided estimate is within plus or minus 25% of the actual cost, it was considered 
correct. A 25% margin is the most commonly used similar studies.26 As a sensitivity analy-
sis, all models are re-estimated with a 35% margin of error and findings from the statistical 
results remain consistent.
A paired two-sample t-test compared the accuracy rate between pharmaceutical items and 
medical devices. A two-sample t-test determines the likelihood that the average difference 
between two groups is truly significant as opposed to resulting from random chance. We 
check for significant differences in mean accuracy of physicians based on education, spe-
cialty, and hospital affiliation.
Results
Sample Statistics
The survey was completed by 106 physicians. Table 1 summarises demographic infor-
mation gathered from the survey. Only four respondents indicated a lack of familiarity 
with at least one item, and their rate of correct responses was adjusted accordingly. Four 
other observations were missing some demographic data and were included in the anal-
ysis when possible.
The years of professional clinical experience among participants varied between one year 
to 45 years, with an average of 7.2 years of work experience and a standard deviation of 7.3. 
Approximately 60 percent of the respondents held the title of Resident, Assistant Registrar 
or Registrar, with the rest holding more senior positions. The most common specialisation 
among respondents was Internal Medicine, which is to be expected since Internal Medi-
cine departments are the largest in each of Kuwait’s general public hospitals. 
In 2015, Kuwait reported a total of 8,105 physicians practicing in the public sector. Just 
over half (i.e., 4,285) of all physicians practice at one of the six general public hospitals 
in the country, and another 1,371 practice at tertiary care hospitals.27 In the sample, 76 
percent of respondents were practicing at general hospitals.
26   Allan, Lexchin, and Wiebe, ‘Physician Awareness of Drug Cost’. 
27   Kuwait Ministry of Health, ‘Annual Health Report 2015: 52nd Edition’. 
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Table 1: Sample Descriptive Statistics (n=104)
n %
Gender
Male 63 61.0
Female 41 39.0
Education
Kuwait University 54 51.9
Royal College of Surgeons in Ireland 13 12.5
Other 33 31.7
Undisclosed 4 3.8
Years of Experience
0–5 55 52.9
6–10 25 24.0
11–15 12 11.5
16–20 3 2.9
Over 20 years 5 4.8
Undisclosed 4 3.8
Institution Type
General Hospital 79 76.0
Specialised 8 7.7
Primary Care or Other 9 8.7
Undisclosed 8 7.7
Physician Estimation Accuracy
Considering a 25% margin of error, physicians gave an accurate cost estimate for an 
average of 3.1 of the 18 items (17.9% of the time) with a standard deviation of 1.90. With a 
35 percent margin of error, physician estimates were accurate 24% of the time on average. 
With a 15% margin of error, accurate physician estimates dropped to an average of just 
9.6%. In terms of the magnitude of estimation error, the median physician deviation from 
actual costs was 75% on average.
Physicians overestimated the cost of drugs with an actual price of less than 5 KWD and 
underestimated the cost of drugs more expensive than 5 KWD. Physician cost estimates 
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were most inaccurate for the two cheapest drugs on the list, Tramal and Clexane. In 
terms of medical supplies, physicians underestimated the cost of supplies included in the 
survey, with the exception of the two cheapest devices. Figure 1 illustrates the frequency 
that physicians underestimated or overestimated drugs and supplies.
As observable in Figure 1, physicians provided accurate estimates of drug prices (µ=0.22 
σ=0.032) more often than they did for medical supplies (µ=0.14 σ=0.018).28 The difference 
was statistically tested via a paired two-sample t-test (t=3.77, df=103, p<0.01) and found to 
be significant, based on an α of 0.05. The median deviation of the estimates from actual 
costs for drugs and medical supplies was 85 and 81 percent, respectively. A two-sample 
t-test shows no statistical significance between the accuracy rates of locally trained versus 
internationally trained physicians (t = -1.58, df = 102, p = 0.12). 
Figure 1: Frequency of Physician Cost Estimations, By Item Category (N=104)
The mean accuracy of Internal Medicine physicians was compared against the mean 
accuracy of all other specialties. Internal Medicine is the most common specialty both 
in Kuwait’s physician population and our sample. Other specialties could not be isolated 
due to limited observational data in each group. In terms of drug cost accuracy, Internal 
Medicine physicians, on average, had 4.7 accurate drug cost estimates compared to 3.9 
accurate estimates by physicians of other specialties, a statistically significant difference 
(t = -2.61, df = 102, p = 0.01). 
When it comes to medical devices, there was no significant difference between the average 
accuracy of estimates given for Internal Medicine versus other specialties. A comparison 
28   The symbols µ and σ represent the average and standard deviation of the discussed measure, 
respectively. The t-statistic (t), degrees of freedom (df) and p-value (p) describe the result of the t-test. 
In layman’s term, the p-value denotes the probability that the tested difference in means is due to 
random occurrences. 
0%
20%
40%
60%
80%
Drugs Supplies
Underestimated Accurate Overestimated
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of groups of physicians working at different institutions showed no significant difference 
in mean accuracy rates across groups.
Physician Perceptions of Medical Supply Costs
Figure 2 provides histograms of the four general survey questions related to supply costs. 
The specific questions asked, and definitions of their 1 to 5 scales are included in Appen-
dix A. Generally, ‘1’ indicated low agreement to the survey item and ‘5’ indicated high 
agreement.
Physicians believed that cost is an important supply selection criterion for clinically 
equivalent items but indicated a low level of accessibility to cost information at their 
institutions. Physicians also reported that their clinical knowledge of the medical items 
presented in the survey was relatively high while their cost knowledge was low, as mea-
sured by the confidence in the cost estimates they provided. Cost knowledge was positively 
and significantly correlated with the experience (R = 0.27, p<0.05). No other metric was 
correlated with experience nor gender. 
Figure 2: Physician Perceptions of Supply Costs (N=104)
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1 2 3 4 5
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40%
60%
1 2 3 4 5
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Discussion
Research Findings
Previous studies have examined physician cost perceptions, and most have concluded 
that physicians have limited knowledge of medical care costs.29 This study extends 
this line of inquiry by widening the scope of supplies to include both pharmaceutical 
drugs and medical devices and considers the factors associated with higher physician 
awareness. The distinction between drugs and devices is important because drugs 
are discretely classified, with regulated pricing, a high level of price transparency, and 
product substitutability. Medical devices, on the other hand, do not share any of these 
characteristics, posing a challenge for both hospital material managers and physicians 
in selection and pricing.30
Physician cost perceptions of pharmaceutical supplies in this study are consistent with 
results from previous studies, summarised in a systematic review by Allan et al.31 Across 
12 studies that applied the same margin of error (± 25%), the median accuracy rate was 
29%. The median accuracy rate of drugs in this study was 25%. This study further adds 
that cost perceptions of medical devices are significantly less accurate than perceptions 
of the costs of drugs. One reason may be that the price variation of drugs is lower than 
that of devices. The middle 80% price range of all drugs registered in Kuwait is between 
0.820 KWD and 19.500 KWD.32 While we do not have similar data for medical device 
prices, it is safe to assume that they would exhibit a much wider price range.
Consistent with previous studies, physicians generally overestimated the cost of drugs. 
Our findings add that medical device prices were much more likely to be underesti-
mated than overestimated (Figure 1). An underestimation of supply costs can lead to 
a significant amount of waste. For example, a recent study estimated that $968 worth 
of unused supplies (about 13 percent of the total procedure cost) go to waste in each 
neurosurgery operation.33 The authors also indicate that the surgeon was an important 
predictor of the amount of waste per surgery. This observation provides an indication 
that changing surgeon behaviour (through education, incentives or directives) can 
improve cost efficiency.
Seventy percent of physicians indicated that cost was an ‘important’ or ‘very important’ 
29   Allan, Lexchin, and Wiebe, ‘Physician Awareness of Drug Cost’. 
30   Burns et al., ‘Implant Vendors and Hospitals’; Pauly and Burns, ‘Price Transparency For Medical 
Devices’; Joseph Walker, ‘Medical Technology Firms Branch Out’, Wall Street Journal, 1 February 2016, 
sec. Business, http://www.wsj.com/articles/medical-technology-firms-branch-out-1454364767; Wenzl 
and Mossialos, ‘Prices For Cardiac Implant Devices May Be Up To Six Times Higher In The US Than In 
Some European Countries’. 
31   Allan, Lexchin, and Wiebe, ‘Physician Awareness of Drug Cost.’
32   State of Kuwait Ministry of Health, ‘Drug & Food Supplement Prices’. 
33   Study was carried out at the University of California, San Francisco. Corinna C. Zygourakis et al., 
‘Operating Room Waste: Disposable Supply Utilization in Neurosurgical Procedures’, Journal of 
Neurosurgery 126, no. 2 (1 February 2017): pp. 620–25, https://doi.org/10.3171/2016.2.JNS152442
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criterion in selecting between clinically equivalent supply alternatives. However, phy-
sicians also indicated very limited access to cost information at their institutions. This 
contrast is illustrated in Figure 2 and is reflective of the low level of generic drugs substi-
tution in Kuwait.34 Making supply cost information more accessible may be an effective 
approach to motivate the prescription of generic drugs. 
Cost transparency and accessibility may be an effective cost containment strategy in some 
circumstances, such as with pharmaceuticals, where generic alternatives are readily avail-
able with well-established clinical equivalency. However, price transparency alone may be 
less effective as product complexity increases, partly due to physician–supplier relation-
ships and marketing. Our results show substantially lower accuracy in gauging medical 
device costs. More efforts may need to be invested in educating physicians about their 
role in the supply chain. Combining clinical knowledge with an awareness of product 
alternatives, distribution channels and costs can make a difference in supply chain perfor-
mance.35 On the other hand, aligning physician incentives with cost efficiency objectives 
may trigger adverse consequences, such as comprising the patient’s quality of care or 
encouraging opportunistic behaviour. 
Policy Implications and Recommendations 
The results of this research provide some guidance to policymakers for improving supply 
cost efficiency. To become benevolent stewards of the healthcare supply chain, physicians 
would require three elements: information, incentives and education. Empowering physi-
cians allows them to make decisions and improvements in the system that consider costs.
Increasing Availability of Medical Supply Information
Information useful to improve supply selection decision-making includes product char-
acteristics and pricing, potential product alternatives, efficacy studies and so forth. The 
Ministry of Health’s current drug look-up e-service is a start, but it should be greatly 
developed to assist local doctors and augment international medical drug databases. 
For example, the e-service currently does not allow for searching generic drug names for 
brand alternatives and prices. Information about medical devices is even harder to come 
by, both in Kuwait and worldwide. Establishing product equivalency between device alter-
natives is much more difficult than pharmaceuticals, but can prove to be rewarding given 
the huge price variations among the former.36
When information is not readily available, it should be created. Senior physicians in each 
34   IMS Health, ‘Market Overview 2016, Kuwait’. 
35   Korn et al., ‘Improving Physicians’ Knowledge of the Costs of Common Medications and Willingness 
to Consider Costs When Prescribing | SpringerLink’. 
36   Wenzl and Mossialos, ‘Prices For Cardiac Implant Devices May Be Up To Six Times Higher In The US 
Than In Some European Countries’. 
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specialty can form ‘value analysis teams’ to study and consider all aspects of product 
alternatives used in common diagnoses or procedures in that discipline. They can then 
recommend best practices and steer the product choice for less experienced physicians.37 
Specialised committees composed of clinicians, procurement analysts, actuaries and 
perhaps economists could publish nation-wide clinical standards and best practices that 
consider the financial and clinical aspects of treatment and technology choices. 
Aligning Physician and Hospital Incentives
Incentivising physicians towards more cost-effective healthcare delivery is also necessary 
to improve performance. However, one must caution about the unintended consequences 
of incentive plans that may give rise to self-serving behaviours by physicians. Further 
research with underpinnings in agency theory and stewardship theory may help identify 
the right contract structures to set up successful incentive schemes.38 The gain-sharing 
model is one incentive structure that motivates physicians to consider supply costs while 
also accounting for clinical outcomes.39 In other countries, bundled payment programs 
push physicians to account for costs when planning out a treatment strategy or operating 
procedure.40 In instances where treatment costs trickle down to patients, physicians will 
have to pay closer attention to their prescription habits to cater to their clients both clini-
cally and financially. The United Arab Emirates recently launched an effort to increase the 
accountability of drug expenditure by transferring the cost difference between the generic 
and brand drugs onto the patient should a physician prescribe a branded drug.41 Manu-
facturers of brand drugs will also have the incentive to push their prices down to remain 
competitive or risk alienating the physicians prescribing their products.
Educating Physicians About Supply Chain Management
Supply chain education directed towards physicians are generally absent in medical 
programs worldwide. Physicians represent a crucial node in the supply chain of pharma-
ceuticals and medical devices, yet they are neither aware of the hospital’s procurement 
process, nor their significant role in it. An introductory-level course about hospital man-
agement that covers topics in operations management, finance, inventory management, 
strategy and human resource scheduling could shape physician behaviours and elevate 
37   Kathryn Lang and Bradley Eaton, ‘The Value Analysis Team: A Shared Mental Model’, The Health Care 
Manager 28, no. 2 (June 2009): pp. 165–71, https://doi.org/10.1097/HCM.0b013e3181a2cc61
38   Abdulsalam et al., ‘The Impact of Physician-Hospital Integration on Hospital Supply Management’. 
39   Jonathan D. Ketcham and Michael F. Furukawa, ‘Hospital-Physician Gainsharing In Cardiology’, 
Health Affairs 27, no. 3 (1 May 2008): pp. 803–12, https://doi.org/10.1377/hlthaff.27.3.803
40   Thomas C. Tsai et al., ‘Medicare’s Bundled Payment Initiative: Most Hospitals Are Focused On A Few 
High-Volume Conditions’, Health Affairs 34, no. 3 (1 March 2015): pp. 371–80, https://doi.org/10.1377/
hlthaff.2014.0900
41   Sharmila Dhal, ‘Generic Drugs Can Be Cheaper than Branded Ones by 60 Percent in Abu Dhabi’, Gulf 
News, 15 August 2018, https://gulfnews.com/uae/generic-drugs-can-be-cheaper-than-branded-ones-by-
60-per-cent-in-abu-dhabi-1.2266675
Yousef Abdulsalam 17 
their role to that of stewards of the hospital itself, rather than just of the patient. 
Healthcare institutions should also consider including these topics as part of an orienta-
tion program upon recruitment. Future research needs to explore the prevalence of such 
programs around the world and assess their overall efficacy on various dimensions of 
hospital performance, including supply management. Combining clinical knowledge with 
an awareness of supply management, distribution channels and costs has been shown to 
improve supply chain performance.42
Future Research
Future research should consider a more refined sample to answer questions pertaining to 
specific physician groups. For example, past research has focused on the cost perceptions 
of medical items in supply-intensive settings, and where physicians have more selection 
options, such as in orthopedic surgery.43 Furthermore, considering the moderating effect of 
different governance structures and physician employment contracts may prove insight-
ful.44 For example, comparing physicians in private hospitals, public hospitals, primary 
care clinics and specialised private practices may reveal differences in cost awareness and 
attention. These directions of future research can also resolve a limitation in the current 
study related to the convenience sampling approach, which may introduce bias.
Another track of research should also examine the effects of physician perceptions on 
costs. Are supply resources utilised more strategically when there is a higher cost aware-
ness among physicians? Past studies indicate that simply displaying the cost of medications 
and laboratory tests on the computerised physician order entry screens can influence 
physician prescribing behaviours and reduce overall costs without adversely impact the 
quality of care.45 While such studies are encouraging, the causal logic between physician 
cost awareness and cost reduction requires further research.
Another avenue for future research is to consider the role and perceptions of other stake-
holders, such as supplier representatives, patients, and hospital’s procurement agents. 
With increased access to health information via the internet, affluent patients are becom-
ing more involved in their diagnoses and treatment plans. In what situations do informed 
patients improve cost efficiency? On the one hand, patients who may sometimes pay out-
of-pocket for drugs or medical supplies are expected to be more cost-conscious. On the 
other hand, patients with public health coverage are more inclined to request the costliest 
42   Korn et al., ‘Improving Physicians’ Knowledge of the Costs of Common Medications and Willingness 
to Consider Costs When Prescribing | SpringerLink’. 
43   Okike et al., ‘Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They Implant’. 
44   Abdulsalam et al., ‘The Impact of Physician-Hospital Integration on Hospital Supply Management’. 
45   Korn et al., ‘Improving Physicians’ Knowledge of the Costs of Common Medications and Willingness 
to Consider Costs When Prescribing | SpringerLink’; Y. C. Lin and S. R. Miller, ‘The Impact of Price 
Labeling of Muscle Relaxants on Cost Consciousness among Anesthesiologists’, Journal of Clinical 
Anesthesia 10, no. 5 (August 1998): pp. 401–3.
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alternative for peace of mind. This is evident in patient perceptions of generic medica-
tions, where they acknowledge the cost-saving potential of generic drugs but are uneager 
to use them.46 In Kuwait’s context, the changing reimbursement structure for citizens 
versus temporary residents may provide a good natural experiment to test physician cost 
knowledge and prescription behaviours.
Conclusion
Opportunities to improve performance in the supply chains of the health sector remain 
plentiful. This paper considers one avenue, which involves the role of physicians in supply 
selection and their potential impact on hospital costs. Our findings indicate that physi-
cians have little awareness about the costs of supplies that they select and use in their 
service delivery. Accurate information regarding medical device costs appears to be even 
more elusive to physicians than for pharmaceutical items. While pharmaceutical costs at 
hospitals in mature healthcare systems are relatively well managed, medical devices con-
tinue to pose a challenge across may health systems worldwide.47
In Kuwait, the containment of pharmaceutical costs remains a major opportunity with 
only about 20 percent of drugs dispensed being generic, compared to 80 percent or more 
in mature health systems.48 The United Arab Emirates has recently taken a major step 
towards supply cost containment by mandating the dispensing of generic drugs at phar-
macies for insured patients, with patients able to opt to buy branded drugs by paying the 
cost difference out of their pocket.49 Educating physicians about supply expenses and 
simplifying their choices are policies that would represent great strides towards improving 
the efficiency of supply spending in Kuwait’s healthcare system.
46   William H. Shrank et al., ‘Patients’ Perceptions Of Generic Medications’, Health Affairs (Project Hope) 
28, no. 2 (2009): pp. 546–56, https://doi.org/10.1377/hlthaff.28.2.546
47   Wenzl and Mossialos, ‘Prices For Cardiac Implant Devices May Be Up To Six Times Higher In The US 
Than In Some European Countries’. 
48   Shrank et al., ‘The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective 
Than Thought, And May Save Money.’
49   Dhal, ‘Generic Drugs Can Be Cheaper than Branded Ones by 60 Percent in Abu Dhabi.’
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Appendix A
Survey  Instrument
Section 1. Pharmaceuticals and Medical Supply Costs
How much do you estimate the following medical items cost the hospital, in Kuwaiti Dinars? 
Please provide an educated guess of the value (in KWD) for each of the following items.  
Input ‘-1’ if you do not recognise the medical item
Pharmaceutical Supply Costs
Plavix (Clopidogrel) - Tablet, 28 x 75 mg [numerical input]
Gasec (Omeprazole) - Tablet, 28 x 20 mg [numerical input]
Tramal (Tramadol) - Tablet, 10 x 100 mg [numerical input]
Clexane (Enoxaparin) Syringe, 2 x 0.4mL [numerical input]
Amoxil (Amoxcillin) - Tablet, 20 x 500 mg [numerical input]
Rocephin (Ceftriaxone) - I.V. Vial, 1 g [numerical input]
Klacid (Clarithromycin) - Tablet, 20 x 500 mg [numerical input]
Augmentin (amoxicillin/clavulanate) - Tab, 14 x 1 g [numerical input]
Medical Supplies & Devices Costs
Laprascope - Stryker IDEAL EYES Standard [numerical input]
Arterial Blood Gas (ABG) Needle - Pack of 100 [numerical input]
Blood, 500 ml, (O, Rh Positive) [numerical input]
Foley’s Catheter (All-Silicone) [numerical input]
Guidewire for PTCA procedure [numerical input]
Diagnostic Catheter [numerical input]
Cardiac Pacemaker - St. Jude Assurity [numerical input]
Bare Metal Stent [numerical input]
Drug-Eluting Stent [numerical input]
Bio-Absorbable Stent [numerical input]
Section 2. General and Demographic Questions
Please rate your overall familiarity with the medical items listed in this survey. 1 to 5 scale (1 = ‘low’, 5 = ‘high’)
Please rate your overall confidence in the cost estimates you provided. 1 to 5 scale (1 = ‘low’, 5 = ‘high’)
How important do you think the cost is in selecting between two clinically 
equivalent alternatives?
1 to 5 scale (1 = ‘not important’, 
5 = ‘very important’)
How accessible is supply cost information at your hospital? 1 to 5 scale (1= ‘not at all,’ 5= 
‘easily accessible’)
Are you aware of the Kuwait Ministry of Health’s drug prices look-up e-service? [Yes] or [No]
What is your gender? [Male] or [Female]
What is your medical specialty? [Text input]
Current Medical Level? [Text input]
Where did you receive your medical education? [Text input]
Which year did you graduate medical school? [numerical input]
Do you work in a private institution or practice? [Yes] or [No]
Which institution have you worked in the longest? [Text input]
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